·Î±×ÀÎ Àüü´º½º¿ÀÇǴϾðEnglishÆÊ ¾ÆÄ«µ¥¹ÌÆÊ½ºÅ¸Å¬·´TVÆÊµµ¶ó¸®Äí¸£Æ®DPºÎµ¿»êÀλ絿Á¤Event & Çмú¼¼¹Ì³ªµ¶ÀÚÁ¦º¸
°Ë»ö ä¿ëÁ¤º¸ ±º»ê½Ã¾à, ±º»ê°æÂû¼¿¡ ±¸±ÞÇÔ Àü´Þ ±â»çÀÔ·Â : 07.05.28 16:23:53 0 °¡ ÇÃÄ£Ãß°¡ ±èÁ¾±æ ¼Àå°ú ¾à°èÇö¾È ³íÀÇ...¹è°æ¼± ȸÀå µî Âü¼® Àü¶óºÏµµ ±º»ê½Ã¾à»çȸ(ȸÀå ¹è°æ¼±)´Â Áö³ 22ÀÏ ±º»ê°æÂû¼ ±èÁ¾±æ ¼ÀåÀ» ¿¹¹æ, ¾à°èÇö¾ÈÀ» ³íÀÇÇÏ°í ±¸±ÞÇÔ(»óºñ¾à) 6¼ÂÆ®¸¦ Àü´ÞÇß´Ù. À̳¯ Àü´Þ½Ä¿¡´Â ¹è°æ¼± ȸÀåÀ» ºñ·Ô ¹Ú¿ì¼º Á÷Àü ȸÀå, À¯±Í¿Á ±º»ê½Ã¿©¾à»çȸÀå, ¼ÛºÀ¼® Ãѹ«°¡ Âü¼®ÇßÀ¸¸ç ¹éÄ¥Á¾ ÀüºÏ¾à»çȸÀå, ±æ°¼· ÀüÁÖ¾à»çȸÀåÀÌ ¹è¼®Çß´Ù. X AD ÅëÁõ°úÇРŸÀÌ·¹³î! À̺¥Æ®Âü¿© ¡æ ¹ÚÂùÇÏ ±âÀÚ(chpark@dailypharm.com) ±ÛÀÚÅ©±â ¼³Á¤ °¡³ª´Ù¶ó¸¶¹Ù»ç °¡³ª´Ù¶ó¸¶¹Ù»ç °¡³ª´Ù¶ó¸¶¹Ù»ç Senior Associate, PV (Pharmacovigilance) ¹Ù·Î°¡±â Çâ³² °øÀå Á¦Á¶°ü¸®¾à»ç °æ·Âä¿ë ¹Ù·Î°¡±â º»»ç Medical Affairs ä¿ë(°ø°í¿¬Àå) ¹Ù·Î°¡±â RA Assistant Specialist (Contract) ½ÅÀÔ °¡´É ¹Ù·Î°¡±â [Á¦¾à»ç¾÷ºÎ¹®] °³¹ßÆÀ(RA) ¾à»ç ½ÅÀÔ/°æ·Â ä¿ë ¹Ù·Î°¡±â ÃæºÏ À½¼º Á¦Á¶°ü¸®¾à»ç °æ·Â¹«°ü ¹Ù·Î°¡±â MCE Strategy & Operations Specialist (»êÈÞ´ëü ÆÄ°ßÁ÷) ¹Ù·Î°¡±â º»»ç ½ÅÀÔ RA ¾à»ç ä¿ë ¹Ù·Î°¡±â ¿ëÀÎ ¹é¾Ï°øÀå ǰÁú°ü¸® ¾à»ç ä¿ë(½ÅÀÔ/°æ·Â) ¹Ù·Î°¡±â Çѱ¹¿¡ÀÚÀÌ Market Access Leader ä¿ë ¹Ù·Î°¡±â Á¤±ÔÁ÷ ¾à¹«Á÷(ÆÀÀå) ¾à»ç ä¿ë °ø°í ¹Ù·Î°¡±â °æ³² ÇԾȰøÀå ǰÁú°ü¸® ¾à»ç ä¿ë(½ÅÀÔ/°æ·Â) ¹Ù·Î°¡±â [Çѵ¶] MA, Àü¹®ÀǾàǰ/ÀϹÝÀǾàǰ ¸¶ÄÉÆÃ, ÇØ¿Ü¿µ¾÷, CRA, ÀÇ·á±â±â Service Business, ¾à»ç, ±â¼úÆÀ ±³Á¤´ã´ç, Çѵ¶ÇコÄÉ¾î °æ¿µ°ü¸®,Ãѹ« ÆÀÀå ¹Ù·Î°¡±â [¾à»ç »ý»êº»ºÎÀå:°øÀåÀå]´ëÇüÄÚ½ºÇÇÁ¦¾à»ç(´ëÀü) ¹Ù·Î°¡±â ¼¿ïƯº°½Ã Á¾·Î±¸ ÀÓ±âÁ¦°ø¹«¿ø(¾à»ç) ÀÓ¿ë°èȹ Àç°ø°í ¹Ù·Î°¡±â °¸ª°øÀå Á¦Á¶°ü¸®¾à»ç °æ·Â¹«°ü ¹Ù·Î°¡±â 0/300 ÀÌ¿ë¾à°ü | °³ÀÎÁ¤º¸ Ãë±Þ¹æÄ§ | ¹ýÀû°íÁö Copyright ¨Ï Dailypharm 1999-2025,All rights reserved. ¸ÞÀϺ¸³»±â ±â»çÁ¦¸ñ : ±º»ê½Ã¾à, ±º»ê°æÂû¼¿¡ ±¸±ÞÇÔ Àü´Þ URLº¹»ç ¸ÞÀÏ Æ®À§ÅÍ ÆäÀ̽ººÏ īī¿À½ºÅ丮 īī¿ÀÅå ¹êµå ³×À̹ö
ä¿ëÁ¤º¸ ±º»ê½Ã¾à, ±º»ê°æÂû¼¿¡ ±¸±ÞÇÔ Àü´Þ ±â»çÀÔ·Â : 07.05.28 16:23:53 0 °¡ ÇÃÄ£Ãß°¡ ±èÁ¾±æ ¼Àå°ú ¾à°èÇö¾È ³íÀÇ...¹è°æ¼± ȸÀå µî Âü¼® Àü¶óºÏµµ ±º»ê½Ã¾à»çȸ(ȸÀå ¹è°æ¼±)´Â Áö³ 22ÀÏ ±º»ê°æÂû¼ ±èÁ¾±æ ¼ÀåÀ» ¿¹¹æ, ¾à°èÇö¾ÈÀ» ³íÀÇÇÏ°í ±¸±ÞÇÔ(»óºñ¾à) 6¼ÂÆ®¸¦ Àü´ÞÇß´Ù. À̳¯ Àü´Þ½Ä¿¡´Â ¹è°æ¼± ȸÀåÀ» ºñ·Ô ¹Ú¿ì¼º Á÷Àü ȸÀå, À¯±Í¿Á ±º»ê½Ã¿©¾à»çȸÀå, ¼ÛºÀ¼® Ãѹ«°¡ Âü¼®ÇßÀ¸¸ç ¹éÄ¥Á¾ ÀüºÏ¾à»çȸÀå, ±æ°¼· ÀüÁÖ¾à»çȸÀåÀÌ ¹è¼®Çß´Ù. X AD ÅëÁõ°úÇРŸÀÌ·¹³î! À̺¥Æ®Âü¿© ¡æ ¹ÚÂùÇÏ ±âÀÚ(chpark@dailypharm.com) ±ÛÀÚÅ©±â ¼³Á¤ °¡³ª´Ù¶ó¸¶¹Ù»ç °¡³ª´Ù¶ó¸¶¹Ù»ç °¡³ª´Ù¶ó¸¶¹Ù»ç Senior Associate, PV (Pharmacovigilance) ¹Ù·Î°¡±â Çâ³² °øÀå Á¦Á¶°ü¸®¾à»ç °æ·Âä¿ë ¹Ù·Î°¡±â º»»ç Medical Affairs ä¿ë(°ø°í¿¬Àå) ¹Ù·Î°¡±â RA Assistant Specialist (Contract) ½ÅÀÔ °¡´É ¹Ù·Î°¡±â [Á¦¾à»ç¾÷ºÎ¹®] °³¹ßÆÀ(RA) ¾à»ç ½ÅÀÔ/°æ·Â ä¿ë ¹Ù·Î°¡±â ÃæºÏ À½¼º Á¦Á¶°ü¸®¾à»ç °æ·Â¹«°ü ¹Ù·Î°¡±â MCE Strategy & Operations Specialist (»êÈÞ´ëü ÆÄ°ßÁ÷) ¹Ù·Î°¡±â º»»ç ½ÅÀÔ RA ¾à»ç ä¿ë ¹Ù·Î°¡±â ¿ëÀÎ ¹é¾Ï°øÀå ǰÁú°ü¸® ¾à»ç ä¿ë(½ÅÀÔ/°æ·Â) ¹Ù·Î°¡±â Çѱ¹¿¡ÀÚÀÌ Market Access Leader ä¿ë ¹Ù·Î°¡±â Á¤±ÔÁ÷ ¾à¹«Á÷(ÆÀÀå) ¾à»ç ä¿ë °ø°í ¹Ù·Î°¡±â °æ³² ÇԾȰøÀå ǰÁú°ü¸® ¾à»ç ä¿ë(½ÅÀÔ/°æ·Â) ¹Ù·Î°¡±â [Çѵ¶] MA, Àü¹®ÀǾàǰ/ÀϹÝÀǾàǰ ¸¶ÄÉÆÃ, ÇØ¿Ü¿µ¾÷, CRA, ÀÇ·á±â±â Service Business, ¾à»ç, ±â¼úÆÀ ±³Á¤´ã´ç, Çѵ¶ÇコÄÉ¾î °æ¿µ°ü¸®,Ãѹ« ÆÀÀå ¹Ù·Î°¡±â [¾à»ç »ý»êº»ºÎÀå:°øÀåÀå]´ëÇüÄÚ½ºÇÇÁ¦¾à»ç(´ëÀü) ¹Ù·Î°¡±â ¼¿ïƯº°½Ã Á¾·Î±¸ ÀÓ±âÁ¦°ø¹«¿ø(¾à»ç) ÀÓ¿ë°èȹ Àç°ø°í ¹Ù·Î°¡±â °¸ª°øÀå Á¦Á¶°ü¸®¾à»ç °æ·Â¹«°ü ¹Ù·Î°¡±â 0/300 ÀÌ¿ë¾à°ü | °³ÀÎÁ¤º¸ Ãë±Þ¹æÄ§ | ¹ýÀû°íÁö Copyright ¨Ï Dailypharm 1999-2025,All rights reserved. ¸ÞÀϺ¸³»±â ±â»çÁ¦¸ñ : ±º»ê½Ã¾à, ±º»ê°æÂû¼¿¡ ±¸±ÞÇÔ Àü´Þ URLº¹»ç ¸ÞÀÏ Æ®À§ÅÍ ÆäÀ̽ººÏ īī¿À½ºÅ丮 īī¿ÀÅå ¹êµå ³×À̹ö
ä¿ëÁ¤º¸ ±º»ê½Ã¾à, ±º»ê°æÂû¼¿¡ ±¸±ÞÇÔ Àü´Þ ±â»çÀÔ·Â : 07.05.28 16:23:53 0 °¡ ÇÃÄ£Ãß°¡ ±èÁ¾±æ ¼Àå°ú ¾à°èÇö¾È ³íÀÇ...¹è°æ¼± ȸÀå µî Âü¼® Àü¶óºÏµµ ±º»ê½Ã¾à»çȸ(ȸÀå ¹è°æ¼±)´Â Áö³ 22ÀÏ ±º»ê°æÂû¼ ±èÁ¾±æ ¼ÀåÀ» ¿¹¹æ, ¾à°èÇö¾ÈÀ» ³íÀÇÇÏ°í ±¸±ÞÇÔ(»óºñ¾à) 6¼ÂÆ®¸¦ Àü´ÞÇß´Ù. À̳¯ Àü´Þ½Ä¿¡´Â ¹è°æ¼± ȸÀåÀ» ºñ·Ô ¹Ú¿ì¼º Á÷Àü ȸÀå, À¯±Í¿Á ±º»ê½Ã¿©¾à»çȸÀå, ¼ÛºÀ¼® Ãѹ«°¡ Âü¼®ÇßÀ¸¸ç ¹éÄ¥Á¾ ÀüºÏ¾à»çȸÀå, ±æ°¼· ÀüÁÖ¾à»çȸÀåÀÌ ¹è¼®Çß´Ù. X AD ÅëÁõ°úÇРŸÀÌ·¹³î! À̺¥Æ®Âü¿© ¡æ ¹ÚÂùÇÏ ±âÀÚ(chpark@dailypharm.com) ±ÛÀÚÅ©±â ¼³Á¤ °¡³ª´Ù¶ó¸¶¹Ù»ç °¡³ª´Ù¶ó¸¶¹Ù»ç °¡³ª´Ù¶ó¸¶¹Ù»ç
0/300 ÀÌ¿ë¾à°ü | °³ÀÎÁ¤º¸ Ãë±Þ¹æÄ§ | ¹ýÀû°íÁö Copyright ¨Ï Dailypharm 1999-2025,All rights reserved. ¸ÞÀϺ¸³»±â ±â»çÁ¦¸ñ : ±º»ê½Ã¾à, ±º»ê°æÂû¼¿¡ ±¸±ÞÇÔ Àü´Þ URLº¹»ç ¸ÞÀÏ Æ®À§ÅÍ ÆäÀ̽ººÏ īī¿À½ºÅ丮 īī¿ÀÅå ¹êµå ³×À̹ö